TLDR New treatments for epidermolysis bullosa show promise in improving patients' lives, but a cure is still not available.
Epidermolysis bullosa (EB) is a severe genetic skin disorder with no current cure, but recent advances in treatment methods, such as gene therapy, protein replacement, and cell therapy, have shown promise in clinical applications. These methods, along with tissue engineering and gene editing, aim to modify the disease and improve patients' quality of life. Although a cure remains elusive, preliminary human trials and animal models have raised hopes for effective management of EB and potentially other genetic diseases.
133 citations
,
July 2020 in “Cells” Creating fully functional artificial skin for chronic wounds is still very challenging.
56 citations
,
March 2016 in “International Wound Journal” Skin grafts are effective for chronic leg ulcers, especially autologous split-thickness grafts for venous ulcers, but more data is needed for diabetic ulcers.
97 citations
,
May 2019 in “Frontiers in Cell and Developmental Biology” Abnormal ECM and immune cell interactions can cause skin diseases.
November 2023 in “Linköping University medical dissertations” Keratinocytes and adipose-derived stem cells can effectively heal difficult skin wounds.
71 citations
,
February 2020 in “Journal of Translational Medicine” Progress has been made in skin and nerve regeneration, but more research is needed to improve methods and ensure safety.
25 citations
,
November 2014 in “Ageing Research Reviews” Skin aging is caused by stem cell damage and can potentially be delayed with treatments like antioxidants and stem cell therapy.
15 citations
,
February 2021 in “Cells” Transfected cells with VEGF and FGF2 genes improve skin wound healing by enhancing blood flow and regeneration.